Member Info for Gilders01

Roses, Ok I give you that one, it is still Christmas,
A Happy and Prosperous New Year to all.

Roses, I'm counting how many times you post the same comments x2 so far and counting.

The RNS Wed, 9th Jan 2019 10:41. They have endorsed the Gov 10 year plan. Therefore I thought they have applied for the grant?

Any chartist had a look at the chart?

If the product is good, the share price doesn't matter, and will correct itself. I'm still hanging in there, I don't know why, just will.

I think it is a must for a big Pharmaceutical company to do a deal with Val. It can be manufactured very cheap so a smaller competitor could take a big part of their business. Merry Christmas and New year to all .
(Was hard to say after the year we have had)

Lunatic, dont get too upset, still hope.

Which has a big impact for patients. You must also take into account the total cost of bringing the cost to market.

I am sure pharma giant AstraZeneca, only want the best.

In London, FTSE 100 pharma giant AstraZeneca announced the USD181 million sale of the rights to Arimidex and Casodex in Europe, Africa and certain other countries.

The drugs, which are mainly used to treat breast and prostate cancer, have been sold to Juvise Pharmaceuticals. AstraZeneca sold the rights to the drugs in the US in 2017. Interesting

So, from that report our real value should be around 7p

Well, roses lets hope they have a good product.

I'd wash their mouths out with soap and water.

My trade, (not that one) excact time, date, size. The next the excact details shown as a cancelled trade. Other times amount show wrong then corrected next day with missing amount same details

We have something to sell, in the biggest part of the market. looks good to me.

Where's the Great in the BritishBulldog

British bulldog. blocks , this British company,

Any company, that wants to, or has business, with the rest of the world should benefit from recent events.

I only post on ADVFN to improve my grammar, spelling and punctuation.

What Is a Stock Basher?
A stock basher is a person engaging in an illegal type of market manipulation to make the price of an asset fall. Stock bashers rely on misinformation campaigns to decrease confidence in a stock, leading to an undervaluation of that stock. In some cases, a stock basher may have a position in the asset which benefits from a fall in price.